Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#21 / 200 Total
CMAX - CareMax Inc - Stock Price Chart
TickerCMAX [NASD, RUT]
CompanyCareMax Inc
CountryUSA
IndustryHealth Information Services
Market Cap9.12MEPS (ttm)-161.56
P/E-EPS this Y86.71%
Forward P/E-EPS next Y38.21%
PEG-EPS past 5Y-
P/S0.01EPS next 5Y-
P/B0.15EPS Q/Q-4113.58%
Dividend-Sales Q/Q-7.57%
Insider Own38.16%Inst Own45.43%
Insider Trans0.00%Inst Trans-13.09%
Short Float9.86%EarningsMar 18/b
Analyst Recom3.00Target Price4.80
Avg Volume88.67K52W Range2.48 - 126.00
CareMax, Inc. provides medical services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation. The company was founded by Carlos de Solo and Alberto de Solo in 2011, and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Omachonu VincentDirectorMay 12 '23Option Exercise0.0016,187029,687May 16 08:48 PM
RDI - Reading International Inc - Stock Price Chart
TickerRDI [NASD]
CompanyReading International Inc
CountryUSA
IndustryEntertainment
Market Cap37.12MEPS (ttm)-1.38
P/E-EPS this Y21.14%
Forward P/E-EPS next Y55.47%
PEG-EPS past 5Y-
P/S0.17EPS next 5Y-
P/B1.12EPS Q/Q7.36%
Dividend-Sales Q/Q-4.00%
Insider Own25.26%Inst Own46.58%
Insider Trans0.00%Inst Trans-3.97%
Short Float0.55%EarningsApr 01/b
Analyst Recom3.00Target Price2.00
Avg Volume15.24K52W Range1.68 - 3.35
Reading International, Inc. is an entertainment and real estate company, which engages in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through the Cinema Exhibition and Real Estate segments. The Cinema Exhibition segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, City Cinemas, 44 Union Square, and Liberty Theatres brands. The Real Estate segment consists of real estate development and the rental or licensing of retail, commercial and live theater assets. The company was founded by James J. Cotter Sr. in 1999 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CUBAN MARK10% OwnerSep 14 '23Sale20.352004,070172,355Sep 15 04:05 PM
CUBAN MARK10% OwnerSep 13 '23Sale20.211,81336,641172,555Sep 15 04:05 PM
CUBAN MARK10% OwnerSep 12 '23Sale20.2290018,196174,368Sep 13 04:05 PM
CUBAN MARK10% OwnerSep 11 '23Sale20.202,06941,795175,268Sep 13 04:05 PM
CUBAN MARK10% OwnerSep 08 '23Sale20.0460012,025177,337Sep 11 04:05 PM
LEV - Lion Electric Co - Stock Price Chart
TickerLEV [NYSE]
CompanyLion Electric Co
CountryCanada
IndustryFarm & Heavy Construction Machinery
Market Cap218.27MEPS (ttm)-0.46
P/E-EPS this Y31.77%
Forward P/E-EPS next Y57.25%
PEG-EPS past 5Y-
P/S0.86EPS next 5Y-
P/B0.59EPS Q/Q-988.74%
Dividend-Sales Q/Q29.21%
Insider Own48.77%Inst Own5.58%
Insider Trans0.00%Inst Trans9.33%
Short Float5.42%EarningsFeb 29/b
Analyst Recom2.33Target Price2.55
Avg Volume517.32K52W Range1.01 - 2.68
The Lion Electric Co. manufactures zero-emission vehicles, which creates, designs, and manufactures all-electric class 5 to class 8 commercial urban trucks and all-electric buses and minibuses for the school, paratransit, and mass transit markets. It offers electric transportation, builds and assembles all of its vehicle components, including chassis,battery packs, truck cabins and bus bodies. The company was founded by Marc Bedard and Camile Chartrand in 2008 and is headquartered in Montreal, Canada.
BNGO - Bionano Genomics Inc - Stock Price Chart
TickerBNGO [NASD]
CompanyBionano Genomics Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap48.20MEPS (ttm)-6.64
P/E-EPS this Y72.17%
Forward P/E-EPS next Y32.98%
PEG-EPS past 5Y23.59%
P/S1.33EPS next 5Y-
P/B0.37EPS Q/Q26.29%
Dividend-Sales Q/Q30.51%
Insider Own1.07%Inst Own10.11%
Insider Trans0.00%Inst Trans-14.14%
Short Float8.70%EarningsMar 05/a
Analyst Recom1.50Target Price6.67
Avg Volume1.60M52W Range0.79 - 9.02
Apr-17-24 08:00AM Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence (GlobeNewswire)
Apr-11-24 08:00AM Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing (GlobeNewswire)
Apr-04-24 01:44PM Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire)
Apr-03-24 08:00AM Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics (GlobeNewswire)
Apr-02-24 08:00AM Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys System at the American Association for Cancer Research Annual Meeting (GlobeNewswire) -6.78%
Mar-19-24 08:00AM Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance (GlobeNewswire)
Mar-07-24 11:47AM Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:00AM Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company's New Stratys System (GlobeNewswire)
Mar-06-24 06:44AM Q4 2023 Bionano Genomics Inc Earnings Call (Thomson Reuters StreetEvents)
12:30AM Bionano Genomics (BNGO) Q4 2023 Earnings Call Transcript (Motley Fool)
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mamuszka HannahDirectorJun 13 '23Buy0.7665,78950,00065,789Jun 14 06:32 PM
Holmlin R. ErikPresident and CEOMay 16 '23Buy0.6415,0009,639806,474May 16 06:23 PM
Stewart Christopher P.Chief Financial OfficerMay 12 '23Buy0.6750,00033,415281,373May 16 06:22 PM
NUWE - Nuwellis Inc - Stock Price Chart
TickerNUWE [NASD]
CompanyNuwellis Inc
CountryUSA
IndustryMedical Devices
Market Cap1.77MEPS (ttm)-13.46
P/E-EPS this Y76.69%
Forward P/E-EPS next Y44.88%
PEG-EPS past 5Y84.44%
P/S0.20EPS next 5Y-
P/B0.49EPS Q/Q55.23%
Dividend-Sales Q/Q9.06%
Insider Own0.07%Inst Own3.13%
Insider Trans0.00%Inst Trans1.34%
Short Float12.08%EarningsMar 05/b
Analyst Recom2.00Target Price1.50
Avg Volume565.40K52W Range0.27 - 5.73
Apr-09-24 09:00AM Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow System at Henry Ford Health (GlobeNewswire)
Mar-07-24 09:08AM Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference (GlobeNewswire)
Mar-05-24 08:00AM Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire) -16.76%
Feb-27-24 09:00AM Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024 (GlobeNewswire) -11.26%
Feb-22-24 07:58AM Nuwellis' Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune (GlobeNewswire)
Feb-20-24 05:06PM Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +16.41%
08:42AM Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference (GlobeNewswire)
Feb-06-24 09:00AM New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload (GlobeNewswire) -7.29%
Jan-04-24 03:05PM Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter (GlobeNewswire) -14.64%
Nov-28-23 08:00AM New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients (GlobeNewswire)
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
OPTT - Ocean Power Technologies - Stock Price Chart
TickerOPTT [AMEX]
CompanyOcean Power Technologies
CountryUSA
IndustrySpecialty Industrial Machinery
Market Cap11.59MEPS (ttm)-0.52
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y48.68%
P/S2.35EPS next 5Y-
P/B0.46EPS Q/Q-1.65%
Dividend-Sales Q/Q144.14%
Insider Own7.22%Inst Own6.85%
Insider Trans0.00%Inst Trans-13.16%
Short Float5.29%EarningsMar 13/a
Analyst Recom1.00Target Price60.00
Avg Volume566.72K52W Range0.20 - 0.77
Ocean Power Technologies, Inc. engages in commercializing proprietary systems that generate electricity predominantly by harnessing the renewable energy of ocean waves. It offers PB3 PowerBuoy, which generates electricity by harnessing the renewable energy of ocean waves. It operates through the following geographical segments: North and South America, Europe, and Asia and Australia. The company was founded by George W. Taylor on April 19, 1984 and is headquartered in Monroe Township, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Slaiby Peter E.DirectorSep 28 '23Buy0.3925,0009,75096,577Oct 02 09:15 AM
Powers Robert PatrickSenior VP and CFOSep 18 '23Buy0.4012,3454,95028,888Sep 20 04:05 PM
Stratmann PhilippPresident and CEOSep 15 '23Buy0.4112,1154,99993,807Sep 18 05:18 PM
ASTI - Ascent Solar Technologies Inc - Stock Price Chart
TickerASTI [NASD]
CompanyAscent Solar Technologies Inc
CountryUSA
IndustrySolar
Market Cap2.04MEPS (ttm)-58.14
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y86.24%
P/S4.44EPS next 5Y-
P/B-EPS Q/Q89.59%
Dividend-Sales Q/Q-78.04%
Insider Own12.35%Inst Own2.07%
Insider Trans0.26%Inst Trans-
Short Float3.90%Earnings-
Analyst Recom-Target Price-
Avg Volume1.08M52W Range0.10 - 80.00
Ascent Solar Technologies, Inc. engages in the design, development, and manufacture of solar technology and power solutions for remote locations and extreme environments. It integrates photovoltaic (PV) modules into a variety of applications such as aerospace, defense, transportation, and electronic products. The company was founded by Mohan S. Misra and Joseph H. Armstrong on October 18, 2005 and is headquartered in Thornton, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Forrest Reynolds T.DirectorNov 01 '23Buy0.853,5293,00058,243Nov 20 07:34 PM
Forrest Reynolds T.DirectorOct 24 '23Buy1.142,6312,99954,714Nov 20 07:34 PM
Forrest Reynolds T.DirectorSep 28 '23Buy2.8852,083149,99952,083Oct 02 05:14 PM
Warley Paul P.Chief Executive OfficerSep 28 '23Buy2.8834,72299,99938,222Oct 02 04:50 PM
THOMPSON GREGORY CDirectorSep 28 '23Buy2.8817,36150,00017,361Oct 02 04:23 PM
VLCN - Volcon Inc - Stock Price Chart
TickerVLCN [NASD]
CompanyVolcon Inc
CountryUSA
IndustryAuto Manufacturers
Market Cap4.25MEPS (ttm)-344.02
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.30EPS next 5Y-
P/B-EPS Q/Q95.38%
Dividend-Sales Q/Q44.20%
Insider Own11.17%Inst Own0.18%
Insider Trans0.00%Inst Trans61.21%
Short Float1.87%EarningsOct 31/b
Analyst Recom1.00Target Price675.00
Avg Volume4.56M52W Range0.23 - 337.50
Volcon, Inc. engages in the design and development of electric outdoor power sports vehicles. It also offers electric two and four-wheel motorcycles and utility terrain vehicles. The company was founded by Christian Gerard Okonsky and Adrian James on February 21, 2020 and is headquartered in Round Rock, TX.
KYTX - Kyverna Therapeutics Inc. - Stock Price Chart
TickerKYTX [NASD]
CompanyKyverna Therapeutics Inc.
CountryUSA
IndustryBiotechnology
Market Cap819.71MEPS (ttm)-
P/E-EPS this Y96.35%
Forward P/E-EPS next Y-22.14%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own58.16%Inst Own3.25%
Insider Trans8.96%Inst Trans-
Short Float8.02%EarningsMar 26/a
Analyst Recom1.00Target Price42.75
Avg Volume497.06K52W Range20.10 - 35.06
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company. It develops treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GILEAD SCIENCES, INC.10% OwnerFeb 12 '24Buy22.00910,00020,020,0004,126,119Feb 13 05:48 PM
Northpond Ventures III GP, LLCFormer 10% OwnerFeb 12 '24Buy22.00450,0009,900,000450,000Feb 12 05:51 PM
Bain Capital Life Sciences Inv10% OwnerFeb 12 '24Buy22.00450,0009,900,0003,163,868Feb 14 05:26 PM
Vida Ventures, LLC10% OwnerFeb 12 '24Buy22.00253,1365,568,992252,553Feb 14 07:04 PM
TXG - 10x Genomics Inc - Stock Price Chart
TickerTXG [NASD]
Company10x Genomics Inc
CountryUSA
IndustryHealth Information Services
Market Cap3.47BEPS (ttm)-2.18
P/E-EPS this Y27.06%
Forward P/E-EPS next Y45.69%
PEG-EPS past 5Y-13.04%
P/S5.60EPS next 5Y-
P/B4.65EPS Q/Q-175.27%
Dividend-Sales Q/Q17.76%
Insider Own17.70%Inst Own75.69%
Insider Trans-0.27%Inst Trans-1.00%
Short Float8.65%EarningsApr 30/a
Analyst Recom1.75Target Price53.57
Avg Volume1.37M52W Range29.12 - 63.57
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Saxonov SergeChief Executive OfficerMar 04 '24Sale44.004,660205,021842,900Mar 06 04:12 PM
Saxonov SergeChief Executive OfficerFeb 22 '24Sale46.342,821130,737847,560Feb 26 04:13 PM
Hindson Benjamin J.See RemarksFeb 22 '24Sale46.342,613121,098283,059Feb 26 04:12 PM
McAnear Justin J.Chief Financial OfficerFeb 22 '24Sale46.341,86586,43295,240Feb 26 04:12 PM
Saxonov SergeChief Executive OfficerFeb 15 '24Sale48.875,000244,332850,381Feb 20 04:20 PM
123456781020